AAAAAA
Results:
1-7
|
Results: 7
Authors:
Duplantier, AJ
Beckius, GE
Chambers, RJ
Chupak, LS
Jenkinson, TH
Klein, AS
Kraus, KG
Kudlacz, EM
McKechney, MW
Pettersson, M
Whitney, CA
Milici, AJ
Citation: Aj. Duplantier et al., Isoxazolyl, oxazolyl, and thiazolylpropionic acid derivatives as potent alpha(4)beta(1) integrin antagonists, BIOORG MED, 11(19), 2001, pp. 2593-2596
Authors:
Kuperman, AV
Kalgutkar, AS
Marfat, A
Chambers, RJ
Liston, TE
Citation: Av. Kuperman et al., Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: In vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue, DRUG META D, 29(11), 2001, pp. 1403-1409
Authors:
Chambers, RJ
Marfat, A
Citation: Rj. Chambers et A. Marfat, An improved synthesis of 5-fluorothiophene-2-carboxylic acid, SYN COMMUN, 30(19), 2000, pp. 3629-3632
Authors:
Chambers, RJ
Marfat, A
Citation: Rj. Chambers et A. Marfat, Leukotriene antagonists: patent highlights 1996-1998, EXPERT OP T, 9(1), 1999, pp. 19-26
Authors:
Chambers, RJ
Marfat, A
Antognoli, GW
Cheng, JB
Damon, DB
Kuperman, AV
Liston, TC
Mebus, C
Pillar, JS
Shirley, JT
Watson, JW
Citation: Rj. Chambers et al., Discovery of CP-199,330 and CP-199,331: Two potent and orally efficacious cysteinyl LT1 receptor antagonists devoid of liver toxicity, BIOORG MED, 9(18), 1999, pp. 2773-2778
Authors:
Graham, MM
Chambers, RJ
Davies, RF
Citation: Mm. Graham et al., Angiographic quantification of diffuse coronary artery disease: Reliability and prognostic value for bypass operations, J THOR SURG, 118(4), 1999, pp. 618-627
Authors:
Chambers, RJ
Antognoli, GW
Cheng, JB
Kuperman, AV
Liston, TC
Marfat, A
Owens, BS
Pillar, JS
Shirley, JT
Watson, JW
Citation: Rj. Chambers et al., Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists, BIOORG MED, 8(24), 1998, pp. 3577-3582
Risultati:
1-7
|